355
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes

, &
Pages 689-696 | Received 06 Jul 2011, Accepted 09 Apr 2012, Published online: 07 Jun 2012

References

  • American Speech-Language-Hearing Association. 1994. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA, 36, 11–19.
  • Brown A.M., Kemp D.T. 1984. Suppressibility of the 2f1-f2 stimulated acoustic emissions in gerbil and man. Hear Res, 13, 29–37.
  • Dille M.F., McMillan G.P., Reavis K.M., Jacobs P., Fausti S.A. . 2010. Ototoxicity risk assessment (ORA) combining distortion product otoacoustic emissions (DPOAE) with a cisplatin dose model. J Acoust Soc Am, 128, 1163–1174.
  • Dille M.F., McMillan G.P., Wilmington D., Fausti S.A. & Konrad-Martin D. 2012. Development and validation of a cisplatin dose- ototoxicity model. J Am Acad Audiol. 23, 510–521.
  • Goldstein J.L. & Kiang N-Y. S. 1967. Neural correlates of the aural combination tone 2f1-f2. Proc. IEEE, 1968; 56, 981–992.
  • Hastie T., Tibshirani R. & Friedman J. 2009. The Elements of Statistical Learning, 2nd ed. Springer Series in Statistics. New York.
  • He N.J. & Schmiedt R.A. 1993. Fine structure of the 2f1-f2 acoustic distortion product: Changes with primary level. J Acoust Soc Am, 94, 2659–2669.
  • Kim D.O. 1980. Cochlear mechanics: Implications of electrophysiological and acoustical observations. Hear Res, 2, 297–317.
  • Martin G.K., Lonsbury-Marti B.L., Probst R., Scheinin S.A. & Coats A.C. 1987. Acoustic distortion products in rabbit ear canal. II. Sites of origin revealed by suppression contours and pure tone exposures. Hearing Research, 28, 191–208.
  • Mauermann M. & Kollmeier B. 2004. Distortion product otoacoustic emission (DPOAE) input/output functions and the influence of the second DPOAE source. J Acoust Soc Am, 116(4 Pt 1), 2199–212.
  • Neely S.T. & Liu Z. 1993. EMAV: Otoacoustic emission averager. Tech Memo No 17 (Boys Town National Research Hospital, Omaha).
  • Obuchowski N.A. 1997. Nonparametric analysis of clustered ROC curve data. Biometrics, 53, 567–78.
  • Rao A. & Long G.R. 2011. Effects of aspirin on distortion product fine structure: Interpreted by the two-source model for distortion product otoacoustic emissions generation. J Acoust Soc Am, 129, 792–800.
  • Shera C.A. & Zweig G. 1993. Noninvasive measurement of the cochlear traveling-wave ratio. J Acoust Soc Am, 93, 3333–3352.
  • Wagner W., Plinkert P.K., Vonthein R. & Plontke S.K. 2008. Fine structure of distortion product otoacoustic emissions: Its dependence on age and hearing threshold and clinical implications. Eur. Arch. Otorhinolaryngol, 265, 1165–1172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.